Evidence map›Paper›PMID 29206307›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2018

Osteoprotection Through the Deletion of the Transcription Factor Rorβ in Mice.

Joshua N Farr, Megan M Weivoda, Kristy M Nicks, Daniel G Fraser, Brittany A Negley, Jennifer L Onken, Brianne S Thicke, Ming Ruan, Hong Liu, Douglas Forrest and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Consequences of Aging on Bone.Aging and disease · 2023
    Pooled it
  2. Review
  3. RORβ Deficiency Inhibits Endochondral Ossification in Mice by Mediating the HIF-1α/VEGFA Signaling Pathway.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Prostaglandin EStem cell reviews and reports · 2021
    Article
  12. ROR: Nuclear Receptor for Melatonin or Not?Molecules (Basel, Switzerland) · 2021
    Review
  13. miR-219a-5p Regulates Rorβ During Osteoblast Differentiation and in Age-related Bone Loss.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
    Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Joshua N FarrDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Megan M WeivodaDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Kristy M NicksDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Daniel G FraserDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Brittany A NegleyDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Jennifer L OnkenDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Brianne S ThickeDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Ming RuanDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Hong LiuLaboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.
Douglas ForrestLaboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.
John R HawseDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Sundeep KhoslaDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
David G MonroeDepartment of Medicine, Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Mayo Clinic · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

SEX STEROIDS, GROWTH FACTORS, &BONE CELL FUNCTIONP01AG004875 · NIA · MAYO CLINIC ROCHESTER · PI MONROE, DAVID G · 1985 to 2019
$30.8M
Orphan nuclear receptors and mammalian developmentZIADK047035 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI FORREST, DOUGLAS · 2009 to 2025
$8.6M
Role of a TGF-? Regulated Gene in Human and Mouse Osteoblasts and SkeletonR01DE014036 · NIDCR · MAYO CLINIC ROCHESTER · PI HAWSE, JOHN R., SUBRAMANIAM, MALAYANNAN · 2001 to 2016
$4.7M
The Role of Ror-Beta in the SkeletonR01AR068275 · NIAMS · MAYO CLINIC ROCHESTER · PI MONROE, DAVID G · 2015 to 2019
$1.7M
Estrogen receptor regulation of bone metabolism in adult miceR01AG048792 · NIA · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP, MONROE, DAVID G · 2015 to 2019
$1.0M
The Role of Cellular Senescence in Mediating Age-Related Bone LossK01AR070241 · NIAMS · MAYO CLINIC ROCHESTER · PI FARR, JOSHUA NICHOLAS · 2016 to 2020
$640k
Osteoclasts Regulate Osteocyte Viability and FunctionK01AR070281 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEIVODA, MEGAN M · 2016 to 2020
$614k
NIAMS NIH HHS K01 AR070241NIAMS NIH HHS K01 AR070281NIAMS NIH HHS R01 AR068275NIA NIH HHS P01 AG004875NIA NIH HHS R01 AG048792NIDCR NIH HHS R01 DE014036
6 · The paper itself

Abstract

There is a clinical need to identify new molecular targets for the treatment of osteoporosis, particularly those that simultaneously inhibit bone resorption while stimulating bone formation. We have previously shown in overexpression studies that retinoic acid receptor-related orphan receptor β (Rorβ) suppresses in vitro osteoblast differentiation. In addition, the expression of Rorβ is markedly increased in bone marrow-derived mesenchymal stromal cells with aging in both mice and humans. Here we establish a critical role for Rorβ in regulating bone metabolism using a combination of in vitro and in vivo studies. We used Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene editing to demonstrate that loss of Rorβ in osteoblasts enhances Wnt signaling, specifically through increased recruitment of β-catenin to T-cell factor/lymphoid enhancer factor (Tcf/Lef) DNA binding sites in the promoters of the Wnt target genes Tcf7 and Opg. This resulted in increased osteogenic gene expression and suppressed osteoclast formation through increased osteoprotegerin (OPG) secretion in Rorβ-deficient cells. Consistent with our in vitro data, genetic deletion of Rorβ in both female and male mice resulted in preserved bone mass and microarchitecture with advancing age due to increased bone formation with a concomitant decrease in resorption. The improved skeletal phenotype in the Rorβ

Indexed as

Cell DifferentiationOsteogenesisWnt Signaling PathwayAnimalsBone ResorptionCell LineMiceMice, KnockoutNuclear Receptor Subfamily 1, Group F, Member 2OsteoblastsNuclear Receptor Subfamily 1, Group F, Member 2Rorb protein, mouseAGINGOSTEOBLASTSOSTEOCLASTSOSTEOPOROSISTRANSCRIPTION FACTORS

Identifiers

PMID29206307
PMCPMC5925424
OpenAlexW2803165740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.